女性生殖器皮肤癌莫氏显微手术与多学科管理的回顾性病例系列:局部复发率与患者报告结局
该回顾性病例系列纳入2006至2021年在学术中心接受莫氏显微手术治疗女性生殖器皮肤癌的57例患者共60处肿瘤,评估局部复发率、患者报告结局及多学科协作情况。平均随访61.1个月(中位48.8个月)发现3处局部复发;31例完成患者报告结局调查者中71.0%对手术满意,93.5%无尿失禁。作者认为将莫氏显微手术纳入多学科团队可能有助于实现低局部复发率和满意功能。
要点
- 57例患者60处女性生殖器皮肤癌接受莫氏显微手术,常见为鳞状细胞癌26处、基底细胞癌12处、乳房外Paget病11处。
- 平均随访61.1个月(中位48.8个月)共检出3处局部复发。
- 完成患者报告结局调查的31例中,71.0%对莫氏显微手术满意,93.5%报告无尿失禁。
核心结论
- 将莫氏显微手术纳入多学科团队可能有助于在生殖器皮肤癌术后实现低局部复发率和满意的功能结局。
研究设计与样本
- 回顾性病例系列,纳入2006年至2021年在学术中心接受莫氏显微手术治疗的女性生殖器皮肤癌患者。
- 共57例患者、60处皮肤癌;主要结局为局部复发,次要结局为患者报告结局和多学科协作细节。
主要发现
- 常见诊断为鳞状细胞癌(n=26)、基底细胞癌(n=12)和乳房外Paget病(n=11)。
- 平均随访61.1个月(中位48.8个月)期间检出3处局部复发。
- 31例患者完成患者报告结局调查,其中71.0%(22/31)对莫氏显微手术满意,93.5%(29/31)报告无尿失禁。
- 随访时8例有性活动,其中75.0%(6/8)无性功能障碍。
- 71.7%(43/60)的病例涉及多学科协作。
关键数值与推荐
- 局部复发:平均随访61.1个月(中位48.8个月)检出3处局部复发。
- 患者报告结局:31例完成调查,满意率71.0%(22/31),无尿失禁率93.5%(29/31)。
- 性功能:随访时有性活动的8例中,75.0%(6/8)无性功能障碍。
- 多学科协作:71.7%(43/60)的病例涉及多学科协作。
临床怎么用
- 原文结论指出,将莫氏显微手术纳入多学科团队可能有助于在生殖器皮肤癌术后实现低局部复发率和满意的功能结局。
局限性
- 回顾性单中心设计。
- 队列异质性。
- 缺乏术前功能数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conventional excision of female genital skin cancers has high rates of local recurrence and morbidity. Few publications describe local recurrence rates (LRRs) and patient-reported outcomes (PROs) after Mohs micrographic surgery (MMS) for female genital skin cancers. OBJECTIVE: To evaluate LRRs, PROs, and interdisciplinary care after MMS for female genital skin cancers. METHODS: A retrospective case series was conducted of female genital skin cancers treated with MMS between 2006 and 2021 at an academic center. The primary outcome was local recurrence. Secondary outcomes were PROs and details of interdisciplinary care. RESULTS: Sixty skin cancers in 57 patients were treated with MMS. Common diagnoses included squamous cell cancer (n = 26), basal cell cancer (n = 12), and extramammary Paget disease (n = 11). Three local recurrences were detected with a mean follow-up of 61.1 months (median: 48.8 months). Thirty-one patients completed the PROs survey. Most patients were satisfied with MMS (71.0%, 22/31) and reported no urinary incontinence (93.5%, 29/31). Eight patients were sexually active at follow-up and 75.0% (6/8) experienced no sexual dysfunction. Most cases involved interdisciplinary collaboration 71.7% (43/60). LIMITATIONS: Limitations include the retrospective single-center design, heterogeneous cohort, and lack of preoperative function data. CONCLUSIONS: Incorporating MMS into interdisciplinary teams may help achieve low LRRs and satisfactory function after genital skin cancer surgery.
引用
- Nugent ST, Raj LK, Latif NA, et al. A retrospective case series of Mohs micrographic surgery and interdisciplinary management of female genital skin cancers: Local recurrence rates and patient-reported outcomes. J Am Acad Dermatol. 2023. PMID: 36918082. doi:10.1016/j.jaad.2023.02.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。